Nisa Investment Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Sell |
10,193
-4,606
| -31% | -$152K | ﹤0.01% | 1087 |
|
|
2025
Q1 | $595K | Buy |
14,799
+107
| +0.7% | +$4.3K | ﹤0.01% | 954 |
|
|
2024
Q4 | $691K | Sell |
14,692
-370
| -2% | -$17.4K | ﹤0.01% | 975 |
|
|
2024
Q3 | $795K | Buy |
15,062
+430
| +3% | +$22.7K | ﹤0.01% | 911 |
|
|
2024
Q2 | $793K | Buy |
14,632
+7
| +0% | +$379 | 0.01% | 938 |
|
|
2024
Q1 | $1.03M | Sell |
14,625
-5,676
| -28% | -$398K | 0.01% | 874 |
|
|
2023
Q4 | $1.69M | Buy |
20,301
+11
| +0.1% | +$918 | 0.01% | 707 |
|
|
2023
Q3 | $598K | Sell |
20,290
-5
| -0% | -$147 | ﹤0.01% | 1016 |
|
|
2023
Q2 | $662K | Buy |
20,295
+4,590
| +29% | +$150K | ﹤0.01% | 995 |
|
|
2023
Q1 | $553K | Sell |
15,705
-60
| -0.4% | -$2.11K | ﹤0.01% | 1038 |
|
|
2022
Q4 | $722K | Sell |
15,765
-100
| -0.6% | -$4.58K | 0.01% | 1006 |
|
|
2022
Q3 | $755K | Buy |
15,865
+155
| +1% | +$7.38K | 0.01% | 902 |
|
|
2022
Q2 | $617K | Buy |
15,710
+3,500
| +29% | +$137K | 0.01% | 979 |
|
|
2022
Q1 | $449K | Sell |
12,210
-2,585
| -17% | -$95.1K | ﹤0.01% | 1116 |
|
|
2021
Q4 | $491K | Buy |
14,795
+2,095
| +16% | +$69.5K | ﹤0.01% | 1016 |
|
|
2021
Q3 | $454 | Buy |
12,700
+2,080
| +20% | +$74 | ﹤0.01% | 1148 |
|
|
2021
Q2 | $210 | Hold |
10,620
| – | – | ﹤0.01% | 1390 |
|
|
2021
Q1 | $247 | Buy |
10,620
+2,020
| +23% | +$47 | ﹤0.01% | 1413 |
|
|
2020
Q4 | $179K | Sell |
8,600
-1,350
| -14% | -$28.1K | ﹤0.01% | 1515 |
|
|
2020
Q3 | $215K | Buy |
9,950
+2,150
| +28% | +$46.5K | ﹤0.01% | 1283 |
|
|
2020
Q2 | $184K | Buy |
7,800
+300
| +4% | +$7.08K | ﹤0.01% | 1299 |
|
|
2020
Q1 | $88K | Hold |
7,500
| – | – | ﹤0.01% | 1405 |
|
|
2019
Q4 | $80K | Buy |
+7,500
| New | +$80K | ﹤0.01% | 1469 |
|